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A Novel Isoform of Acetylcholinesterase Exacerbates
Photoreceptors Death after Photic Stress
Rinat Kehat,1,2 Esther Zemel,1 Nicolas Cuenca,3 Tama Evron,4 Debra Toiber,4
Anat Loewenstein,5 Hermona Soreq,*,4,6 and Ido Perlman*,1,6
PURPOSE. To study the involvement of stress-induced acetylcho-
linesterase (AChE) expression in light-induced retinal damage
in albino rats.
METHODS. Adult albino rats were exposed for 24 hours to
bright, damaging light. AChE expression was monitored by in
situ hybridization, by histochemistry for AChE activity, and by
immunocytochemistry. An orphan antisense agent (Monarsen;
Ester Neurosciences, Ltd., Herzlia Pituach, Israel) was admin-
istered intraperitoneally to minimize light-induced AChE ex-
pression. The electroretinogram (ERG) was recorded to assess
retinal function.
RESULTS. Twenty-four-hour exposure to bright light caused se-
vere reduction in the ERG responses and augmented expres-
sion of mRNA for the “read-through” variant of AChE (AChE-R)
in photoreceptor inner segments (IS), bipolar cells, and gan-
glion cells. AChE activity increased in IS. The expressed AChE
protein was a novel variant, characterized by an extended N
terminus (N-AChE). Systemic administration of the orphan an-
tisense agent, Monarsen, reduced the photic induction of
mRNA for AChE-R, and of the N-AChE protein. Rats exposed to
bright, damaging light and treated daily with Monarsen exhib-
ited larger ERG responses, relatively thicker outer nuclear layer
(ONL), and more ONL nuclei than did rats exposed to the same
damaging light but treated daily with saline.
CONCLUSIONS. The findings indicate that the photic-induced
novel variant of AChE (N-AChE-R) may be causally involved
with retinal light damage and suggest the use of RNA targeting
for limiting such damage. (Invest Ophthalmol Vis Sci. 2007;48:
1290–1297) DOI:10.1167/iovs.06-0847
Photoreceptor loss is the primary cause of blindness indegenerative diseases such as retinitis pigmentosa and age-
related macular degeneration. Exposure of albino rats to bright
light provides an established model for photoreceptor damage
and is widely used to study the mechanisms underlying stress-
induced photoreceptor injury.1 The extent of retinal damage
caused by exposure to light depends on numerous factors,
including the intensity and color of the light and the duration
of exposure,2 age,3 genotype,4 ocular pigmentation,5 and body
temperature.6 The detailed pathologic mechanism(s) underly-
ing light-induced photoreceptor damage are not yet fully un-
derstood. However, a variety of growth hormones, cytokines,7
and antioxidants8 were found to provide partial protection to
retinal photoreceptors from light damage, suggesting causal
involvement of stress-induced processes.
The acetylcholine (ACh)-hydrolyzing enzyme, acetylcho-
linesterase (AChE) is notably involved in neuronal stress reac-
tions.9 Apart from its crucial role in terminating synaptic trans-
mission10 at cholinergic synapses in the peripheral (PNS) and
central (CNS) nervous systems, AChE also plays morphogenic
roles,11,12 and participates in various stress responses.13 In
mice, neuronal AChE levels are markedly increased after forced
swimming and exposure to anticholinesterases,14 even in brain
regions that do not primarily participate in cholinergic activity.
Stress-induced expression of AChE is accompanied by a prom-
inent shift in the protein C terminus from the “synaptic”
variant to the “read-through” sequence,15 both including the
core domain required for hydrolyzing ACh,9 as described sche-
matically in Figure 1. Alternate promoter usage produces each
of these AChE variants in two versions, differing in the length
of their N-terminal domain.16 Thus, AChE-R can appear either
with a cleavable N-terminal signal peptide or with an extended
N terminus, potentially making it membrane bound (Fig. 1c).
However, the functional role(s) of the extended N-AChE pro-
teins under stressful insults remained to be determined.
The stress-related role of neural AChE was inferred from
experiments in which overexpression of AChE-R mRNA was
suppressed in mice subjected to closed head injury by admin-
istration of Monarsen, an orphan drug antisense oligonucleo-
tide.17 Monarsen reduced the number of dead neurons, and
facilitated neurologic recovery, suggesting that the R-variant(s)
of AChE and/or secondary element(s) induced by overexpres-
sion of AChE-R contributed to neuronal death. This could
reflect a direct contribution of the increased hydrolytic capac-
ity of the induced AChE to reduce the tissue level of acetyl-
choline, promoting inflammation and tissue damage.18 Alterna-
tively, or in addition, stress-induced AChE could selectively
contribute to cellular apoptosis through its noncatalytic prop-
erties, compatible with reports of others.19,20 In that case,
excess AChE could induce cell death in noncholinergic neu-
rons, as well.
The retina, as part of the central nervous system (CNS), may
also depend on morphogenic roles of AChE during develop-
ment and after stress episodes. The importance of AChE gene
expression for retinal development was experimentally vali-
dated in a detailed neuroanatomic survey that demonstrated
impaired formation of the inner retina and degeneration of
photoreceptors in an AChE knockout mouse.21 However,
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these findings are relevant to the embryonic development of
the retina and not to stress-induced malfunction in the adult
retina. We have shown AChE mRNA expression in human adult
photoreceptors22—cells that are not involved in cholinergic
synaptic activity—raising the possibility that AChE in photore-
ceptors exerts stress-related morphogenic function(s). This hy-
pothesis is particularly appealing, since the major excitatory
neurotransmitter of the retina is L-glutamate,23 whereas ACh
plays a limited role in visual information processing within the
retina and is found mainly in amacrine and ganglion cells in the
proximal part of the retina.24,25
We tested the hypothesis that exposure to damaging light is
a stressful event that induces the expression of AChE in the
retina, with particular interest in the photoreceptors. We fur-
ther identified the nature of the induced AChE variant and its
role in retinal damage.
METHODS
Procedure
Adult male Sprague-Dawley albino rats (N  60), weighing 200 to
300 g, were kept for at least 2 weeks in a 12-hour light–dark cycle with
free access to food and water. Rats were exposed for 24 hours, starting
at around 10 AM, at room temperature, to bright white light (260
foot-candles) in a specially designed light chamber, and then returned
to the normal rearing conditions (12-hour light–dark cycle). To assess
retinal function, we recorded the electroretinogram (ERG). For ERG
recordings, rats were anesthetized by an intramuscular injection of
ketamine hydrochloride (3.3 mg/kg), acepromazine maleate (6.7 g/
kg), and xylazine (2 g/kg). At the termination of the ERG follow-up
period, rats were killed by an overdose of sodium pentobarbital,
injected intraperitoneally, and their retinas were prepared for in situ
hybridization (ISH), histochemical evaluation or immunocytochemis-
try. Eyes were enucleated and incubated (1-hour for cryosections and
24-hour for paraffin sections) in 0.1 M phosphate buffer (pH 7.4)
containing 4% paraformaldehyde (4°C).
The rats were treated in compliance with the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research and in accor-
dance with institutional guidelines.
Immunocytochemistry
Cryostat sections were incubated overnight, under agitation, with
affinity-purified primary rabbit antiserum targeted against a synthetic
peptide unique for rodent N-AChE16 at a dilution of 1:100 in 0.1 M PBS
1% Triton X-100. We also used an antibody for the core domain,
common to all AChE variants (N-19; Santa Cruz Biotechnology, Santa
Cruz, CA). Secondary antibodies were donkey anti-rabbit IgG coupled
to fluorescein isothiocyanate (FITC) at a 1:100 dilution and a donkey
anti-goat IgG coupled to Cy3 at a 1:100 dilution. Slides were viewed
using a confocal microscope (Eclipse E600; Nikon, Tokyo, Japan; and
Radiance 2000; Bio-Rad, Hercules, CA) scanning system.
Histochemical Staining for AChE Activity
Cryostat sections were stained for catalytically active AChE according
to Karnovsky and Roots.26 Overnight incubation was done in a medium
containing freshly prepared acetylthiocholine iodide (AThCh) as a
substrate in 0.1 M phosphate buffer (pH 6.0; 0.8 mg/mL), 0.1 M sodium
citrate, 30 mM copper sulfate, distilled deionized water (DDW), and 5
mM potassium ferricyanide. The BChE inhibitor, iso-OMPA (tetraiso-
propylpyrophosphoramide; Sigma-Aldrich, St. Louis, MO) was added
(105 M) to specifically localize AChE activity. The selective AChE
inhibitor BW 284C51 (105 M) was used as a negative control. Brown-
ish staining, resulting from AThCh hydrolysis, was examined under a
light microscope (BH2; Olympus, Tokyo, Japan).
In Situ Hybridization
ISH was performed on paraffin-embedded sections, 5 m thick, as
previously described.13 Hybridization involved overnight incubation at
52°C in hybridization mix with a 5-biotinylated, 2-O-methylated AChE
mRNA probe complementary to either the AChE-S (exon 6) rat isoform:
(5402) 5-CCGGGGGACGUCGGGGUGGGGUGGGGA UGGGCAGAGU-
CUGGGGCUCGUCU-3 (5352); or the AChE-R (intron 4) rat isoform:
(4397) 5-CUAGGGGGAGAAGAGAGGGGUUACAC UGGCGGGCUC-
CCACUCCCCUCCUC-3 (4349). The numbers in parentheses denote
nucleotide positions in the GenBank-deposited sequence (accession
no. M55040; http://www.ncbi.nlm.nih.gov/Genbank; provided in the
public domain by the National Center for Biotechnology Information,
Bethesda, MD).
Analysis
For quantitative analysis of staining in the ISH and histochemistry tests,
we photographed slides and converted the micrograph to grayscale.
Densities of retinal layers were quantified in arbitrary units by densi-
tometry (TINA software ver. 2.10; Raytest, Straubenhardt, Germany).
In each slide, we chose a rectangular window of width smaller than
that of the narrowest layer to be measured, the photoreceptor inner
FIGURE 1. Schematic representation of the mouse AChE gene and its mRNA variants and proteins.
(a) Schematic representation of the AChE gene (exons are shown as boxes and introns as lines). There are
five alternative versions of exon 1 (E1a-E1e) in the mouse AChE gene9 (only the last one is shown). (b)
AChE-mRNA variants may differ due to 3 splicing. The “synaptic” protein product (AChE-S) is membrane
bound and is associated with cholinergic synapses, whereas the “read-through” protein (AChE-R) is
induced by stress in a secreted form. Each of these mRNA variants can appear with a short, conservative
(b) or an extended N terminus (c). It is believed that the proteins with the extended N terminus have
additional means to be anchored to membranes. GR, glucocorticoid response element.
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segments (IS). The same window was used to measure density of the
different retinal layers. Four random measurements were made in each
retinal layer of a given retinal micrograph and averaged. The density of
the outer nuclear layer (ONL) was set as the background, and all
density measurements from other retinal layers were performed rela-
tive to this background. In this manner, we ensured that density
measurements would be independent of technical factors such as
thickness of section, duration of incubation, angle of slicing and others
that may affect absolute density measurements but not relative mea-
surements. Data from retinas of four rats undergoing the same exper-
imental procedure were averaged. Because of the small sample size (n
 4), densitometry measurements were compared for statistical signif-
icance by using the Mann-Whitney nonparametric test.
Antisense Treatment
Monarsen (Ester Neurosciences, Ltd., Herzlia Pituach, Israel) antisense
oligodeoxynucleotide directed against Rat AChE mRNA, a 20-mer oli-
godeoxynucleotide (5-CTGCAATATTTTCTTGCACC-3) complemen-
tary to a sequence in exon 2 of rat AChE mRNA, was used as previously
described.27 A single dose of Monarsen was found to have a transient
action lasting between 24 and 72 hours, depending on the injected
dose.27 Since development of light-induced retinal damage proceeds at
a relatively slow rate, we decided to inject Monarsen on a daily basis
throughout the entire duration of the follow-up (30 days). Intravitreal
injection, the preferred route for retinal treatment, was an unrealistic
solution for the treatment. Because the blood–retinal barrier had been
shown to be disrupted after exposure to bright light,28 we decided to
inject Monarsen intraperitoneally. Experimental rats were treated for
30 days with daily intraperitoneal injections of Monarsen (0.1 mL at a
dosage regimen of 500 g/kg), beginning from 1 day before light
exposure, while rats in the control group were injected intraperitone-
ally each day with an equal volume of saline.
Electroretinogram
The ERG29 is the light-induced electrical activity of the retina that is
used to assess retinal function.30 It is composed of two major compo-
nents; the negative a-wave reflects light-induced electrical activity in
the photoreceptors, whereas the positive b-wave is generated in post-
receptor retinal neurons, mainly ON center bipolar cells.31,32
Rats, kept overnight in total darkness, were anesthetized, as de-
scribed earlier. The pupils were dilated (cyclopentolate hydrochloride
1%), and topical anesthetic drops (benoxinate HCl 0.4%) were used to
assure the animal’s comfort. A heating pad was used to maintain body
temperature at 37°C. ERG responses were recorded simultaneously
from both eyes using corneal electrodes (Medical Workshop, Gro-
ningen, The Netherlands). Light stimuli were obtained from a Ganzfeld
light source (LKC Technologies, Gaithersburg, MD) with a maximum
intensity of 5.76 cd-s/m2.
The amplitude of the ERG a-wave was measured from baseline to
the trough of the wave, whereas the amplitude of the ERG b-wave was
measured from the trough of the a-wave to the peak of the b-wave.
Because the amplitude of the ERG waves depend on the intensities of
the light stimuli, it is customary to assess retinal function quantitatively,
by fitting the response–intensity data to a hyperbolic function33,34:
V/Vmax  I/I  (1)
where V and Vmax are the amplitudes of the ERG waves that are elicited
respectively by a flash of intensity I and by a flash of supersaturating
intensity, and the semisaturation constant  is a measure of retinal
sensitivity.
RESULTS
AChE gene expression is notably subject to complex stress-
induced changes (Fig. 1). To assess the effects of photic stress
on expression and activity of AChE, we compared retinas of 15
albino rats, exposed to bright, damaging light for 24 hours to
those of 15 unexposed control albino rats, raised in a 12-hour
light–dark cycle. After exposure to the bright, damaging light,
all 30 rats were kept in a regular 12-hour light–dark cycle with
no further treatment for the entire 30-days of follow-up (ex-
periment 1). Retinal micrographs from rats participating in this
experiment clearly demonstrated light-induced modifications
in AChE expression and activity (Fig. 2). In the control retina,
ISH (Fig. 2a) predictably indicated very low levels of expres-
sion of mRNA for the AChE-R variant. After exposure to dam-
aging light, expression of AChE-R mRNA was augmented in the
ganglion cells (GCs) and in retinal cells in the INL. However,
the most striking effect was seen in the inner segments (IS) of
the photoreceptors. This effect was noted as early as 1-day after
exposure to damaging light, increased during the next 14 days
(Figs. 2c, 2e, arrowheads), and was seen up to 30 days (data
not shown), the longest period of follow-up. Densitometry
measurements showed a mild, but statistically significant, in-
crease in IS AChE-R mRNA at 1 day after exposure, and a
substantial, statistically significant, increase at 14 days after
exposure to light (Table 1). Expression of AChE-S mRNA,
encoding the synaptic variant of AChE was relatively un-
changed after light exposure, compared with normal rat reti-
nas (data not shown).
The augmented expression of AChE-R mRNA was accompa-
nied by increased cytochemical labeling for total AChE cata-
lytic activity (Fig. 2, right column), albeit at a different pattern.
In the control retina, strong AChE activity was seen in the
proximal parts of the retina (IPL and ganglion cells) and very
weak activity in the photoreceptor inner segments (Fig. 2b),
reflecting the normal activity of the AChE-S variant in the rat
retina.24,25 It should be noted that the staining pattern in the
proximal retina was rather diffuse and lacked the distinct
layered staining,24 probably because we had to incubate the
slices overnight to test for catalytic activity in the photorecep-
tor inner segments. With shorter incubation times (2–4 hours),
the staining pattern in the proximal retina (data not shown),
was very similar to that shown previously.24
At 1 day and 14 days after exposure to bright, damaging
light, AChE activity increased in the photoreceptor inner seg-
ments (Figs. 2d, 2f, arrowheads; Table 1). AChE activity in the
photoreceptors was refractory to iso-OMPA, an inhibitor of the
AChE-homologous protein butyrylcholinesterase (BChE), but
was completely blocked by BW 284C51, a selective inhibitor of
AChE (data not shown), indicating that exposure to bright,
damaging light increased AChE but not BChE activity in the
photoreceptors. It was difficult to appreciate stress-induced
changes in AChE activity in the proximal part of the retina (INL
and GC), because histochemical staining was already high in
the control retinas, obscuring any stress-induced augmenta-
tion. Therefore, photic stress-related changes in AChE activity
were analyzed quantitatively only for the photoreceptor inner
segments (IS in Table 1).
The light-exposure-induced AChE-R accumulation in the
photoreceptor inner segments could be an irrelevant byprod-
uct of the damaging stress. Alternatively, it could have a detri-
mental role promoting light-induced photoreceptor death, or
could be part of a recovery process. To distinguish between
these possibilities, rats were treated daily by intraperitoneal
injection of rat Monarsen, an antisense agent directed against
the consensus domain in AChE mRNA.27,35,36 Treatment initi-
ated 1 day before light exposure and proceeded until the end
of the follow-up period. Control rats in this experiment (ex-
periment 2), were also exposed to the damaging, bright light,
but were injected intraperitoneally daily with saline solution.
We chose intraperitoneal injection for Monarsen administra-
tion, because daily intravitreal injection for 30 consecutive
days was unrealistic, and because previous reports indicated a
breakdown of the blood–retinal barrier after exposure to dam-
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aging light,28 thus providing a simple route for delivering the
antisense agent to the retina.
Figure 3 shows micrographs of retinas that were obtained
14 days after exposure to damaging light and underwent ISH
for AChE-R mRNA (Figs. 3a, 3c), or histochemical staining for
total AChE activity (Figs. 3b, 3d). Sections were derived from
experimental rats treated with Monarsen (Figs. 3c, 3d), and
from control rats treated with saline (Figs. 3a, 3b). It should be
noted that in preliminary experiments, Monarsen treatment,
either by intravitreal injection or by intraperitoneal injection,
exerted no effects on the retinas of rats, which were raised
under a 12-hour light–dark cycle and were not exposed to
bright, damaging light (data not shown), similar to its null
effects in the control brain.37 In contrast, averaged densitom-
etry measurements from retinas of four rats of each group in
this experiment (right of each micrograph) demonstrated that
Monarsen, injected intraperitoneally, predictably crossed the
blood–retinal barrier, reached the retina, and suppressed the
light-induced expression of AChE-R mRNA in all retinal cells,
having the strongest effect in the photoreceptor inner seg-
ments (Fig. 3c, arrowheads). Correspondingly, AChE activity in
the photoreceptor inner segments was considerably weaker in
the retina from rats treated with Monarsen (Fig. 3d, arrow-
heads) compared with those injected with saline (Fig. 3b,
arrowheads). An important finding is that Monarsen did not
alter AChE activity in the proximal retina (IPL and GC), sug-
FIGURE 2. Expression of AChE-R mRNA (ISH) and total AChE activity (cytochemistry) in the retinas of a control rat and of rats exposed to damaging
light and killed 1 day and 14 days after exposure. Average (SEM) densities at the photoreceptors inner segments (IS), inner nuclear layer (INL),
and ganglion cells (GC), obtained from retinas of four rats, are shown to the right of each representative micrograph. AChE-R mRNA was found
at a very low level in control rats (a), but was significantly expressed in rats exposed to bright, damaging light (c, e). Light-induced AChE-R mRNA
expression was evident in ganglion cells (GC), in neurons of the inner nuclear layer (INL), and in the inner segments (IS) of the photoreceptors
(arrowheads). High AChE activity was found in the inner plexiform layer (IPL) of retinas from unexposed control rat (b) and of experimental rats
exposed to damaging light (d, f). AChE activity was also evident in the inner segments of the photoreceptors (arrowheads) of rats exposed to
damaging light (d, f). *Statistically significant differences between light-exposed and control rats (P  0.05).





Experiment 2: 14 Days
after Light Exposure
with Daily Injection
1 Day 14 Days Saline Monarsen
Ph IS (ISH) 1.0 296* 781* 1141 25.5†
INL (ISH) 1.0 1.4 10.2* 12.1 1.0†
GC (ISH) 1.0 0.5 7.4* 5.0 3.2
IS (Cytochemical staining) 1.0 2.0* 3.2* 3.4 1.9†
Effects were measured in photoreceptors inner segments (Ph IS), inner nuclear layer (INL) and
ganglion cells (GC). AChE activity was measured in photoreceptors inner segments (IS). Experiment 1:
Exposure to bright, damaging light and follow-up without any treatment. Experiment 2: Exposure to
bright, damaging light followed by daily intraperitoneal injection of saline or Monarsen (antisense). Values
indicate fold increase of staining relative to the corresponding layer in control rats that were not exposed
to the bright, damaging light. Each value is the average of measurements in retinas from four different rats
undergoing the same experimental procedure.
* Statistically significant (P  0.05) difference when compared to control.
† Statistically significant (P  0.05) difference when compared to rats treated daily with saline.
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gesting that these layers express AChE-S, which is considerably
less sensitive to this agent. This supports previous observations
in rat muscle,27 mouse brain,36 and primate motor neurons,35
indicating that nascent mRNA transcripts of AChE are more
susceptible to the antisense treatment, probably because they
are not yet covered with the protective bulky structure of the
ribosomes and translational protein complexes which engulf
functioning mRNA chains. Reproducible AChE-R suppression
occurred in four rats treated with Monarsen compared with
four control rats. Densitometry measurements were further
used to calculate the effects of saline and Monarsen treatment
on AChE-R mRNA expression in the different retinal layers and
on AChE activity in the photoreceptor inner segments (Table
1). The suppressive effects of Monarsen on light-induced ex-
pression of AChE-R mRNA were statistically significant in pho-
toreceptor inner segments (IS) and in neurons of the INL, but
not in ganglion cells. Monarsen’s effect was also statistically
significant for AChE activity in photoreceptor inner segments
(IS).
An important finding was that expression of AChE-R mRNA
in rats exposed to bright, damaging light and injected daily
with saline was higher, albeit not significantly so, than that of
rats undergoing the same exposure to light without further
treatment (Table 1). This observation suggests that general
trauma to the rat, associated with daily handling and injection
may be also associated with increased expression of retinal
AChE-R.
AChE-R can appear in two forms, one with the conservative
N terminus,38 and the other with an extended N terminus16
(Fig. 1). To study the composition and localization of the
AChE-R protein in photic-stressed retinas, we used a specific
antibody directed at the unique N-terminally extended epitope
of rodent AChE. We compared retinas of control rats that were
not subjected to the damaging light with those undergoing
exposure to damaging light and treated with either saline or
Monarsen. We also tested the retinas for all AChE isoforms,
including those with the shorter, conservative N terminus,
using a commercially available antibody targeted to the core
domain common to all variants (N-19; Santa Cruz Biotechnol-
ogy). The control retina was positively stained for total AChE in
the proximal margin of the INL (amacrine cells), in the IPL and
in ganglion cells, whereas immunostaining of N-AChE was
negligible (Fig. 4, top). A similar distribution of total AChE was
found in the light-exposed rats, injected with saline (Fig. 4;
second row, middle column). Exposure to light also induced
intense labeling for N-AChE in the photoreceptor inner and
outer segments (Fig. 4, second row, arrowheads), and in the
distal portion of the INL (Fig. 4; second row, arrows). From the
location of the stained cells in the INL and their structure, they
appeared to be bipolar cells. Together with the ISH data (Figs.
2, 3), these findings suggest the accumulation of N-AChE-R in
the light-exposed retina. In contrast, the retinal sections from
rats, exposed to damaging light but treated with Monarsen,
showed an immunostaining pattern similar to that of control
rats (Fig. 4, lower row). Weak staining was seen at the photo-
receptor level, and in the distal margin of the INL, suggesting
that Monarsen prevented most, but not all, of the light-induced
expression of N-AChE protein.
To challenge the functional role of AChE-R in light-induced
retinal damage, we recorded the dark-adapted ERG before and
at different time intervals after exposure to bright, damaging
light. The ERG is an excellent test for our goal—that is, assess-
ment of retinal function during an extended period of follow-
up. The ERG reflects light-induced electrical activity of the entire
retina.30 It is composed mainly of two waves: the negative
a-wave reflects light-induced activity in the photoreceptors,
and the positive b-wave is generated in the INL, mainly by
ON-bipolar cells with contribution from Mu¨ller cells.31,32 After
exposure, rats were treated daily with saline (n  10) or
Monarsen (n 10), as described before. The ERG responses of
all light-exposed rats were predictably attenuated, indicating
substantial light-induced retinal damage. However, Monarsen-
treated rats demonstrated ERG responses of considerably larger
amplitude compared with saline-treated rats, as illustrated for
two rats (one of each group) in Figure 5a. These responses
were elicited in the dark-adapted state with the brightest light
stimulus available in our photic stimulation system. Because
the ERG responses depended on the light intensity of the
stimulus used to elicit them, we recorded the ERG responses to
light stimuli of different intensities and constructed the re-
FIGURE 3. The effects of Monarsen, an orphan AChE mRNA-targeted antisense agent, on light-induced expression of AChE-R mRNA and total
activity of AChE. Rats were treated daily with intraperitoneal injection of saline or Monarsen and were killed 14-days after exposure (24 hours) to
bright, damaging light. Average (SEM) density values at the photoreceptors inner segments (IS), inner nuclear layer (INL), and ganglion cells (GC),
obtained from retinas of four rats, are shown to the right of each representative micrograph. AChE-R mRNA and AChE activity were higher in the
retinas of rats, exposed to bright, damaging light, and treated with saline (a, b), compared with light-exposed rats that had been treated with
Monarsen (c, d). Most evident was the effect in the inner segments of the photoreceptors (arrowheads). #Statistically significant differences
between Monarsen- and saline-treated rats (P  0.05).
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sponse–intensity curves for the a- and b-wave, as illustrated in
Figures 5b and 5c for the two rats whose ERG responses are
shown in Figure 5a. The response–intensity data were fitted to
the hyperbolic function (equation 1) and the maximum re-
sponse amplitude (Vmax) of the a- and b-wave were derived.
ERG results, similar to those shown in Figure 5 were ob-
tained from all the rats studied in this experiment. Vmax, de-
rived from the response–intensity data, was averaged accord-
ing to the two treatment groups. Monarsen-treated rats showed
a lesser degree of initial ERG deficits and better recovery of the
a- and b-wave compared with saline-injected rats (Fig. 6). These
differences were significant for the b-wave of all the rats
throughout the follow-up period (P  0.001).
An additional measure, commonly used, for quantitative
assessment of light-induced retinal damage, is the thickness of
the ONL. Because this parameter varies considerably as a func-
tion of retinal eccentricity (distance from the optic disc), along
the vertical meridian,7,39 we measured ONL thickness in the
superior part of the retina 200 m from the optic disc.
Measurements from three control rats (four sections in each
FIGURE 4. Light-induced stress in
turn induces N-AChE production in a
Monarsen-suppressible manner. Im-
munocytochemistry of retinas from
rats exposed to bright, damaging
light and treated with saline (second
row) or Monarsen (third row) are
compared to that of a control rat that
was not exposed to damaging light
(first row). Two antibodies were
used, one against AChE with ex-
tended N terminus (left column) and
the other against the core domain of
all AChE variants (middle column),
as indicated in the scheme above the
micrographs. The two micrographs
of each rat were merged to show the
overlap between the two proteins
(right column). Exposure to damag-
ing light clearly increased expression
of N-AChE in the saline-treated ret-
ina, which was significantly pre-
vented by Monarsen treatment.
N-AChE expression by exposure to
bright light was mainly evident in the
inner and outer segments of the pho-
toreceptors (arrowheads) and in
cells located in the inner nuclear
layer (arrows) as shown in the
merged micrograph (middle row,
right column).
FIGURE 5. The effects of Monarsen on light-induced retinal damage, as assessed by the ERG responses. (a) ERG responses of a Monarsen-treated
rat (bottom) and a saline-treated rat (top) that were recorded at different time intervals after exposure to bright, damaging light. The ERG responses
were elicited from both eyes, using unattenuated bright (log I 0.76 cd-s/m2) light stimuli. To assess the degree of light-damage and the protection
by Monarsen, we constructed the response–intensity relationships of the ERG a-wave and b-wave of the right eye of the control (saline-treated) and
experimental (Monarsen-treated) rats (b, c, respectively), measured before and 30-days after exposure to damaging light. The response–intensity
curves were fitted to the hyperbolic function (equation 1) to derive the maximum response amplitudes (Vmax) of the a- and b-waves.
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rat) that were kept in a 12-hour light–dark cycle and were not
exposed to damaging light yielded an average ONL thickness of
44.1  1.7 m. Similar measurements from saline-treated and
Monarsen-treated rats (three rats in each group, four sections
from each rat), that were prepared for histology 14 days after
24-hour exposure to bright, damaging light, gave the following
average values, respectively: 22  3.0 and 21.5  3.0. Because
the sections varied in total retinal thickness, we normalized
ONL thickness to total retinal thickness. With this approach,
the ONL’s relative thickness in Monarsen-treated rats (0.217 
0.034) was significantly (P  0.05) more than the ONL’s
relative thickness in saline-treated rats (0.160  0.026). We
also counted the number of nuclei in the ONL of these retinas
by using a rectangle of 115 m width and height that was
slightly larger than the width of the ONL. We chose this
approach instead of counting the number of nuclei rows,
because we noticed multiple loci of missing nuclei spread in a
mosaic pattern within the ONL of light-damaged retinas. We
measured 103.3  10.3 nuclei in control rats not exposed to
the damaging bright light. This was significantly (P  0.001)
larger than the number of nuclei in light-damaged retinas re-
gardless of the treatment that was given to the rats. The
number of ONL nuclei in the Monarsen-treated rats (43.8 
7.6) was significantly (P  0.009) larger than the number of
ONL nuclei in the saline-treated rats (31.8  4.4). Thus, the
protective role of Monarsen against light-induced retinal dam-
age was also evident from morphometric measurements.
DISCUSSION
Our findings demonstrate, for the first time, that a “read-
through” isoform of AChE with an extended N terminus is
induced by stress in the mammalian retina. The N-AChE pro-
tein(s) was also observed in other stress-responding parts of
the CNS16; however, our current findings provide the first
direct evidence on both its stress-induced accumulation in
retinal photoreceptors and its causal involvement in the light-
induced death of these cells. This conclusion is based on two
observations. ISH indicated that photic stress induced the ex-
pression of mRNA coding for the “read-through” variant of
AChE, whereas immunostaining indicated expression of a pro-
tein isoform of AChE carrying an extended N terminus. To-
gether, these findings suggest that the N-terminally extended
AChE-R variant (N-AChE-R protein) is expressed in the retinas
of albino rats subjected to photic stress. However, we could
not completely rule out the possibility that N-AChE-S was also
induced by exposure to bright light. We showed that this novel
isoform of AChE exerted antisense-suppressible neuronal cell
damage, as assessed from functional tests (ERG recordings) and
morphometric measurements in the albino rat retina.
In the photic-stressed rats, Monarsen antisense treatment
effectively suppressed the expression of N-AChE (Fig. 4) in the
retina, while enhancing the recovery of treated retinas as
evident from functional tests (Figs. 5, 6) and from morphomet-
ric measurements of ONL thickness. Qualitative ISH analysis
indicated that the Monarsen treatment reduced the expression
of mRNA AChE-R more efficiently than it did for mRNA AChE-S
(data not shown), supporting previous observations of partic-
ular vulnerability of nascent mRNA transcripts to the antisense
effect.27,35,36 These results further suggest that the N-AChE-R
protein (and/or other nascent AChE variants induced under
photic damage, such as N-AChE-S) play a detrimental role,
exacerbating photoreceptor injury after exposure to bright,
damaging light. This role can be explained in at least two
alternative ways. First and foremost, the damaging role of the
expressed AChE may be due to its catalytic activity. ACh has
been shown to suppress the production of proinflammatory
cytokines40 and to act via nicotinic receptors as a neuropro-
tector against excitotoxicity.41,42 In fact, in a mammalian
model of glutamate-induced excitotoxicity, ACh was found to
protect GCs from death.43 Thus, overexpression of AChE by
exposure to bright light may act to reduce the neuroprotection
offered by endogenous ACh. In addition, recent reports show
a nonenzymatic enhancement of apoptosis by AChE in cul-
tured cells.19,20 Because retinal cell death after light exposure
is by apoptosis,44,45 involving light-induced expression of
AP-1,46 our findings may reflect a tissue-specific causal role of
N-AChE-R in the apoptosis of light-stressed photoreceptors.
That suppression of nascent, but not the preexisting AChE,
sufficed to reduce light-induced retinal damage supports the
notion that distinct AChE variants play different roles in the
retina. The similarity of their catalytic properties further supports
the notion that nonenzymatic properties of AChE were involved.
Exposure to damaging light also induced expression of
N-AChE-R in bipolar cells and ganglion cells, raising the possi-
bility that light-induced retinal damage is not limited to the
photoreceptors, but reflects apoptotic processes in a variety of
retinal neurons. Future experiments are needed to find out
whether N-AChE-R accumulates in retinal (and other) neurons
after other stressful episodes such as increased pressure (glau-
coma), metabolic stress (diabetes), and ischemia, where it may
play detrimental role(s) promoting neuronal and specifically
retinal damage.
Antisense treatment has been suggested as a potential ther-
apeutic approach in cases in which specific silencing of gene
expression is desired.47 However, this treatment is considered
to be of limited value in the treatment of neurologic and retinal
diseases because of its restricted transport across the blood–
brain barrier38 and the blood–retinal barrier (BRB). Our current
findings present the photic stress-disrupted BRB28 as an excep-
tion to this rule by demonstrating that intraperitoneally in-
jected Monarsen blocked N-AChE-R expression in the retina.
That photic damage injury facilitates the functioning of Monar-
sen in the retina further raises the possibility of treating other
retinal diseases in which the BRB is damaged (e.g., clinical and
FIGURE 6. The effects of Monarsen
on light-induced retinal damage, as
assessed by the ERG responses. The
maximum amplitudes of the a- and
b-waves were derived from the re-
sponse–intensity curves of saline-
treated (n  10) and Monarsen-
treated rats (n  10). Average (SD)
Vmax compared for the ERG a-wave
(a) and b-wave (b). Monarsen treat-
ment reduced the degree of light-
induced damage, and improved re-
covery from photic stress.
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experimental diabetic retinopathy),48,49 by systemic antisense
administration.
References
1. Stone J, Maslim J, Valter-Kocsi K, et al. Mechanisms of photore-
ceptor death and survival in mammalian retina. Prog Retin Eye
Res. 1999;18:689–735.
2. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms
of light-induced photoreceptor apoptosis and neuroprotection for
retinal degeneration. Prog Retin Eye Res. 2005;24:275–306.
3. O’Steen WK, Anderson KV, Shear CR. Photoreceptor degeneration
in albino rats: dependency on age. Invest Ophthalmol. 1974;13:
334–339.
4. LaVail MM, Gorrin GM, Repaci MA, Yasumura D. Light-induced
retinal degeneration in albino mice and rats: strain and species
differences. Prog Clin Biol Res. 1987;247:439–454.
5. Rapp LM, Williams TP. The role of ocular pigmentation in protect-
ing against retinal light damage. Vision Res. 1980;20:1127–1131.
6. Barbe MF, Tytell M, Gower DJ, Welch WJ. Hyperthermia protects
against light damage in the rat retina. Science. 1988;241:1817–1820.
7. LaVail MM, Unoki K, Yasumura D, et al. Multiple growth factors,
cytokines, and neurotrophins rescue photoreceptors from the
damaging effects of constant light. Proc Natl Acad Sci USA. 1992;
89:11249–11253.
8. Organisciak DT, Darrow RM, Jiang YI, Marak GE, Blanks JC. Pro-
tection by dimethylthiourea against retinal light damage in rats.
Invest Ophthalmol Vis Sci. 1992;33:1599–1609.
9. Meshorer E, Soreq H. Virtues and woes of AChE alternative splicing in
stress-related neuropathologies. Trends Neurosci. 2006;29:216–224.
10. Taylor P, Radic Z. The cholinesterases: from genes to proteins.
Ann Rev Pharmacol Toxicol. 1994;34:281–320.
11. Soreq H, Seidman S. Acetylcholinesterase: new roles for an old
actor. Nat Rev Neurosci. 2001;2:294–302.
12. Behra M, Cousin X, Bertrand C, et al. Acetylcholinesterase is
required for neuronal and muscular development in the zebrafish
embryo. Nat Neurosci. 2002;5:111–118.
13. Meshorer E, Erb C, Gazit R, et al. Alternative splicing and neuritic
mRNA translocation under long-term neuronal hypersensitivity.
Science. 2002;295:508–512.
14. Kaufer D, Friedman A, Seidman S, Soreq H. Acute stress facilitates
long-lasting changes in cholinergic gene expression. Nature. 1998;
393:373–377.
15. Meshorer E, Bryk B, Toiber D, et al. SC35 promotes sustainable
stress-induced alternative splicing of neuronal acetylcholinesterase
mRNA. Mol Psychiatry. 2005;10:985–997.
16. Meshorer E, Toiber D, Zurel D, et al. Combinatorial complexity of
5 alternative acetylcholinesterase transcripts and protein prod-
ucts. J Biol Chem. 2004;279:29740–29751.
17. Shohami E, Kaufer D, Chen Y, et al. Antisense prevention of
neuronal damages following head injury in mice. J Mol Med.
2000;78:228–236.
18. Metz CN, Tracey KJ. It takes nerve to dampen inflammation.
Nature Immunol. 2005;6:756–757.
19. Zhang XJ, Yang L, Zhao Q, et al. Induction of acetylcholinesterase
expression during apoptosis in various cell types. Cell Death
Differ. 2002;9:790–800.
20. Park SE, Kim ND, Yoo YH. Acetylcholinesterase plays a pivotal role
in apoptosome formation. Cancer Res. 2004;64:2652–2655.
21. Bytyqi AH, Lockridge O, Duysen E, et al. Impaired formation of the
inner retina in an AChE knockout mouse results in degeneration of
all photoreceptors. Eur J Neurosci. 2004;20:2953–2962.
22. Broide RS, Grifman M, Loewenstein A, et al. Manipulations of
ACHE gene expression suggest non-catalytic involvement of ace-
tylcholinesterase in the functioning of mammalian photoreceptors
but not in retinal degeneration. Brain Res Mol Brain Res. 1999;
71:137–148.
23. Dowling JE. The Retina: An Approachable Part of the Brain.
Cambridge, MA: Harvard University Press; 1987.
24. Criswell MH, Brandon C. Acetylcholinesterase and choline acetyl-
transferase localization patterns do correspond in cat and rat
retinas. Vision Res. 1993;33:1747–1753.
25. Hutchins JB. Acetylcholine as a neurotransmitter in the vertebrate
retina. Exp Eye Res. 1987;45:1–38.
26. Karnovsky MJ, Roots L. A “direct-coloring” thiocholine method for
cholinesterases. J Histochem Cytochem. 1964;12:219–221.
27. Brenner T, Hamra-Amitay Y, Evron T, et al. The role of readthrough
acetylcholinesterase in the pathophysiology of myasthenia gravis.
FASEB J. 2003;17:214–222.
28. van Best JA, Putting BJ, Oosterhuis JA, Zweypfenning RC, Vrensen
GF. Function and morphology of the retinal pigment epithelium
after light-induced damage. Micro Res Technol. 1997;36:77–88.
29. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in exper-
imental diabetes: electroretinographical and morphological obser-
vations. Exp Eye Res. 2002;74:615–625.
30. Armington JC. The Electroretinogram. New York: Academic Press;
1974.
31. Lei B, Perlman I. The contribution of voltage- and time-dependent
potassium conductances to the electroretinogram in rabbits. Vis
Neurosci. 1999;16:743–754.
32. Ripps H, Witkovsky P. Neuron-glia interaction in the brain and
retina. Prog Retinal Res. 1985;4:181–219.
33. Fulton AB, Hansen RM. Scotopic stimulus/response relations of the
b-wave of the electroretinogram. Doc Ophthalmol. 1988;68:193–
304.
34. Hood DC, Birch DG. A computational model of the amplitude and
implicit time of the b-wave of the human ERG. Vis Neurosci.
1992;8:107–126.
35. Evron T, Ben-Moyal L, Lam N, Soreq H. RNA-targeted suppression
of stress-induced allostasis in monkey spinal cord neurons. Neu-
rodegen Dis. 2005;2:16–27.
36. Nijholt I, Farchi N, Kye M, et al. Stress-induced alternative splicing
of acetylcholinesterase results in enhanced fear memory and long-
term potentiation. Mol Psychiatry. 2004;9:174–183.
37. Cohen O, Erb C, Ginzberg D, et al. Neuronal overexpression of
‘readthrough’ acetylcholinesterase is associated with antisense-
suppressible behavioral impairments. Mol Psychiatry. 2002;7:
874–885.
38. Soreq H, Seidman S. Antisense approach to isoform-specific block-
ade of acetylcholinesterase. In: Crooke ST, ed. Antisense Drug
Technology: Principles, Strategies and Applications. Carlsbad, CA:
Marcel Dekker, Inc.; 2001:565–586.
39. Rapp LM, Naash MI, Wiegand RD, et al. Morphological and bio-
chemical comparison between retinal regions having differing
susceptibility to photoreceptor degeneration. In: LaVail MM, Hol-
lyfield JG, Anderson RE, eds. Retinal Degeneration: Experimental
and Clinical Studies. New York: Alan R. Liss; 1985:421–437.
40. Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway.
Brain Behav Immun. 2005;19:493–499.
41. Stevens TR, Krueger SR, Fitzsimonds RM, Picciotto MR. Neuropro-
tection by nicotine in mouse primary cortical cultures involves
activation of calcineurin and L-type calcium channel inactivation.
J Neurosci. 2003;23:10093–10099.
42. Hejmadi MV, Dajas-Bailador F, Barns SM, Jones B, Wonnacott S.
Neuroprotection by nicotine against hypoxia-induced apoptosis in
cortical cultures involves activation of multiple nicotinic acetyl-
choline receptor subtypes. Mol Cell Neurosci. 2003;24:779–786.
43. Wehrwein E, Thompson SA, Coulibaly SF, Linn DM, Linn CL.
Acetylcholine protection of adult pig retinal ganglion cells from
glutamate-induced excitotoxicity. Invest Ophthalmol Vis Sci.
2004;45:1531–1543.
44. Hafezi F, Marti A, Munz K, Reme CE. Light-induced apoptosis:
differential timing in the retina and pigment epithelium. Exp Eye
Res. 1997;64:963–970.
45. Roca A, Shin K-J, Liu X, Simon MI, Chen J. Comparative analysis of
transcriptional profiles between two apoptotic pathways of light-
induced retinal degeneration. Neuroscience. 2004;129:779–790.
46. Grimm C, Andreas W, Hafezi F, Reme CE. Gene expression in the
mouse retina: the effect of damaging light. Mol Vis. 2000;6:252–
260.
47. Opalinska JB, Gewirtz AM. Therapeutic potential of antisense nu-
cleic acid molecules. Sci STKE. 2003;206:1–5.
48. Cunha-Vaz JG. Studies on the pathophysiology of diabetic
retinopathy: the blood-retinal barrier in diabetes. Diabetes. 1983;
32:20–27.
49. Xu Q, Qaum T, Adamis AP. Sensitive blood–retinal barrier break-
down quantitation using Evans blue. Invest Ophthalmol Vis Sci.
2001;42:789–794.
IOVS, March 2007, Vol. 48, No. 3 Acetylcholinesterase in Photoreceptor Death after Photic Stress 1297
